MEDTOX Laboratories

Medtox System

Since 1984, MEDTOX has been developing innovative products and in 1987, MEDTOX developed the first FDA 510(k)-cleared diagnostics drug-screening device. Since then,  MEDTOX has received FDA 510(k)-clearance on numerous drug-screening devices. All MEDTOX devices are subjected to a strict internal QC/QA process – their performance is measured through ongoing comparison with CAP UDS proficiency specimens.


The system includes the PROFILE®-V MEDTOXScan Test Device and the MEDTOXScan®Reader, which interprets and reports the test results automatically. The test menu is comprehensive with a panel of 12 drugs providing single sample testing to a broad range of drugs. The PROFILE®-V device offers screening results in 10 minutes. Devices are activated by the tester pipetting urine into the sample wells.

Substances Tested For:

  • AMP Amphetamine
  • BAR Barbiturates
  • BZO Benzodiazepines
  • COC Cocaine
  • MAMP Methamphetamine
  • MTD Methadone
  • OPI Opiates
  • OXY Oxycodone
  • PCP Phencyclidine
  • PPX Propoxyphene
  • THC Cannabinoids
  • TCA Tricyclic Antidepressants

The next generation in hospital laboratory drug screening:

  • Easy installation and operation
  • One-step testing process
  • Results in ten minutes
  • Lower clinical cut-off levels
  • Stores up to 1000 results.
  • Eliminates operator result interpretation
  • Can test up to 12 drugs, including Methamphetamine and Oxycodone
  • Ability to report into hospital LIS

Contact us at 780 702 9500 or complete the form.